Statistics for Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice?
Total visits
views | |
---|---|
Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice? | 120 |
Total visits per month
views | |
---|---|
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
main-1.pdf | 127 |
java.util.UUID:351f7c87-9e24-4c8f-9e3b-6d204b573485 | 32 |
java.util.UUID:db0402dd-43b3-4b0b-86f5-584584d74d23 | 7 |
java.util.UUID:b091b2e3-fdcb-424b-8937-847f69f92e3a | 1 |
Top country views
views | |
---|---|
United States | 96 |
Germany | 4 |
Ukraine | 3 |
Canada | 2 |
China | 2 |
Spain | 1 |
United Kingdom | 1 |
India | 1 |
Malaysia | 1 |
Réunion | 1 |
Russia | 1 |
Top city views
views | |
---|---|
Wilmington | 44 |
Fairfield | 13 |
Houston | 9 |
Jacksonville | 5 |
Kiez | 4 |
Kiev | 3 |
Ann Arbor | 2 |
Beijing | 2 |
Cambridge | 2 |
San Francisco | 2 |
Toronto | 2 |
Barcelona | 1 |
Indianapolis | 1 |
Irvine | 1 |
Lake Mary | 1 |
Moscow | 1 |
Seattle | 1 |
Seremban | 1 |